PF-04383119
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-04383119, covering 2021-02-21 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis [Phase 2]